Tarsus Pharmaceuticals, Inc. (TARS)
62.61
+1.34
(+2.19%)
USD |
NASDAQ |
Jun 11, 16:00
62.61
0.00 (0.00%)
After-Hours: 17:34
Tarsus Pharmaceuticals Total Liabilities (Quarterly) : 232.18M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 232.18M |
| December 31, 2025 | 223.47M |
| September 30, 2025 | 199.48M |
| June 30, 2025 | 162.38M |
| March 31, 2025 | 158.29M |
| December 31, 2024 | 152.81M |
| September 30, 2024 | 138.82M |
| June 30, 2024 | 124.60M |
| March 31, 2024 | 74.07M |
| December 31, 2023 | 69.24M |
| September 30, 2023 | 54.67M |
| June 30, 2023 | 41.20M |
| March 31, 2023 | 37.81M |
| Date | Value |
|---|---|
| December 31, 2022 | 34.96M |
| September 30, 2022 | 33.84M |
| June 30, 2022 | 31.32M |
| March 31, 2022 | 32.29M |
| December 31, 2021 | 12.18M |
| September 30, 2021 | 11.27M |
| June 30, 2021 | 10.98M |
| March 31, 2021 | 10.72M |
| December 31, 2020 | 5.992M |
| September 30, 2020 | 6.855M |
| June 30, 2020 | 3.872M |
| March 31, 2020 | |
| December 31, 2019 | 0.919M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Structure Therapeutics, Inc. | 61.03M |
| Eton Pharmaceuticals, Inc. | 67.10M |
| Alumis, Inc. | 104.57M |
| Veradermics, Inc. | 6.716M |
| ANI Pharmaceuticals, Inc. | 859.67M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 581.14M |
| Shareholders Equity (Quarterly) | 348.95M |
| Debt to Equity Ratio | 0.2541 |
| Current Ratio | 3.744 |
| Net Debt Paydown Yield | -0.11% |